3 Followers on Owler
OverviewCompetitorsFundingNews & Insights

POINT Competitors or Alternatives

POINT's top competitors include Orano Med, Fusion Pharma and Telix.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

POINT's company profile

Joe McCann

CEO

90/100
129
$155M
$11.2M
  • $155M
    $11.2M
  • 129
    $155M
  • $11.2M
  • 90/100
  • 129
  • $155M
  • $11.2M
View ProfileView
1
POINT's Competitor - Orano Med logo

Patrick Bourdet

Founder

- -
$326M
  • $326M
  • $326M
  • - -
  • $326M
View ProfileView
2
POINT's Competitor - Fusion Pharma logo

John Valliant

CEO

90/100
113
$363.5M
$2.1M
  • $363.5M
    $2.1M
  • 113
    $363.5M
  • $2.1M
  • 90/100
  • 113
  • $363.5M
  • $2.1M
View ProfileView
3
POINT's Competitor - Telix logo

Christian Behrenbruch

Managing Director & CEO

90/100
234
$143.1M
$342M
  • $143.1M
    $342M
  • 234
    $143.1M
  • $342M
  • 90/100
  • 234
  • $143.1M
  • $342M
View ProfileView
4
POINT's Competitor - RayzeBio logo

Ken Song

President & CEO

90/100
45
$736.9M
  • $736.9M
  • 45
    $736.9M
  • 90/100
  • 45
  • $736.9M
View ProfileView
5
POINT's Competitor - Progenics logo

David W. Mims

Interim-CEO

86/100
100 - 250
$28.9M
$25M - 100M
  • $28.9M
    $25M - 100M
  • 100 - 250
    $28.9M
  • $25M - 100M
  • 86/100
  • 100 - 250
  • $28.9M
  • $25M - 100M
View ProfileView
POINT's top 15 competitors are Orano Med, Fusion Pharma, Telix, QBioMed, RayzeBio, Progenics, Clovis Oncology, Y-mAbs, Actinium, RadioMedix, Novartis, Lantheus, Janssen, Bayer and Ipsen. Together they have raised over 3.2B between their estimated 217.3K employees. POINT has 129 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 14,497.

POINT VS Orano Med

Orano Med is seen as one of POINT's top competitors. Orano Med was founded in 2009, and is headquartered in Plano, Texas. Like POINT, Orano Med also competes in the Pharmaceuticals & Biotechnology industry. Orano Med generates $ less revenue vs. POINT.

POINT VS Fusion Pharma

Fusion Pharma is a top competitor of POINT. Fusion Pharma was founded in 2014, and its headquarters is in Hamilton, Ontario. Like POINT, Fusion Pharma also competes in the Pharmaceuticals field. Fusion Pharma has 16 fewer employees than POINT.

POINT VS Telix

Telix is POINT's #3 rival. Telix was founded in North Melbourne, Victoria} in 2015. Like POINT, Telix also works within the Pharmaceuticals industry. Compared to POINT, Telix generates $330.8M more revenue.

Looking for similar companies to POINT?

Similar Companies

Pharmaceuticals companies in Toronto

See 167 companies 
Pharmaceuticals companies in Ontario

See 482 companies 
Pharmaceuticals & Biotechnology companies in Toronto

See 358 companies 
Pharmaceuticals companies with employees in 100-250 range

See 813 companies 
Pharmaceuticals & Biotechnology companies in Ontario

See 920 companies 
Pharmaceuticals companies in Canada

See 1,055 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,792 companies 
Pharmaceuticals & Biotechnology companies in Canada

See 2,091 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,473 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for POINT and POINT's Competitors

April 1, 2025Marketscreener
NEW YORK , April 1, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investor...
April 1, 2025GlobalNewswire
BURNABY, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Telix ARTMS, Inc. (ARTMS), a global leader in radioisotope production technologies, is pl...
April 1, 2025Benzinga
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH), the leading radiopharmaceutical...
March 31, 2025Pharmabiz
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate─...
March 31, 2025Marketscreener
PHILADELPHIA , March 31, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced an agreement...
March 31, 2025Benzinga
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that...
March 31, 2025Marketscreener
Actinium Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss wa...
April 1, 2025Korea Biomedical Review
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...
April 1, 2025Southcarolina-magazine
DelveInsight's " Cancer Monoclonal Antibodies Market Insights, Competitive Landscape, and Market Forecast-2030 " report provides a comprehensive analys...
March 31, 2025Startupticker
Bayer has launched the "Bayer Co.Lab Connect - Basel", a new program specifically designed to empower early-stage startups as they navigate the U.S. ec...

Frequently Asked Questions about POINT

  1. Who are POINT's top competitors?

    POINT's top 3 competitors are Orano Med, Fusion Pharma, Telix.

  2. Who is similar to POINT?

    Orano Med is the most similar to POINT. Fusion Pharma and Telix are also similar to POINT.

  1. Are POINT and Orano Med competitors?

    Yes, Orano Med is one of POINT’s top competitors.